Intercommunity variations in antidiabetic drug utilization and in prevalence of diabetes mellitus

1994 ◽  
Vol 3 (4) ◽  
pp. 215-221 ◽  
Author(s):  
Jonny Olsson ◽  
Claes Tollin ◽  
Sven Nilsson ◽  
Arne Melander
Keyword(s):  
Diabetes Mellitus ◽  
Drug Utilization ◽  
Antidiabetic Drug ◽  
Prevalence Of Diabetes Mellitus

scholarly journals Ten-Year Trends in the Morbidity of Diabetes Mellitus and Antidiabetic Drug Utilization in Croatia: A Study Based on Routinely Collected Data

2016 ◽  
Vol 2016 ◽  
pp. 1-9 ◽  
Author(s):  
Renata Pavlov ◽  
Ivančica Topličan ◽  
Mladenka Vrcić Keglević
Keyword(s):  
Diabetes Mellitus ◽  
Drug Utilization ◽  
Insulin Analogues ◽  
Annual Reports ◽  
Medicinal Products ◽  
Antidiabetic Drug ◽  
Routinely Collected Data ◽  
Primary Health ◽  
Morbidity Data ◽  
Total Utilization

Objectives. To investigate trends of diabetes mellitus (DM) morbidity and antidiabetic drug utilization in Croatian primary health care (PHC) from 2005 to 2014. Method. Routinely collected morbidity data from all PHC units, presented in Croatian health-statistics yearbooks, were retrieved. Data on drug utilization were retrieved from the Annual Reports of the Croatian Agency for Medicinal Products and Medical Devices (ATC/DDD, antidiabetic, A10). Results. Total morbidity increased by 33.3% and DM increased by 65.6%, mostly in patients over age 65 (from 50% to 57%). Estimated DM prevalence in adults increased from 3.9% to 6.4%. Increased morbidity was followed by an even higher increase in drug utilization (120%). Metformin was first, with a constant increase (from 18% to 39%), followed by glimepiride, while glibenclamide use decreased. Total utilization of insulin increased even more, mostly for aspart (600%) and newly introduced glargine and detemir, while human insulin usage sharply decreased. Spending also increased, mostly for aspart (from 21% to 61% of total). Conclusions. Increased DM is followed by a higher increase in antidiabetic drug utilization; this trend will continue in the future. In Croatian PHC, metformin has primacy along with insulin analogues.

scholarly journals Drug utilization pattern in type II diabetes mellitus patients attending non-communicable disease clinic in a tertiary care hospital

2019 ◽  
Vol 8 (3) ◽  
pp. 539
Author(s):  
Akash Gadgade ◽  
Shwetha B. ◽  
Basavaraj C. Kotinatiot ◽  
Chetan A. C.
Keyword(s):  
Diabetes Mellitus ◽  
Drug Utilization ◽  
Communicable Disease ◽  
Fixed Dose ◽  
Care Hospital ◽  
Antidiabetic Drug ◽  
Disease Clinic ◽  
History Of ◽  
Comorbid Diseases ◽  
Non Communicable Disease

Background: Diabetes mellitus is a metabolic disorder. Early institution of treatment is necessary to prevent complications. Since treatment of diabetes requires lifetime therapy; this study is designed to understand the prescription trends at Non Communicable Disease clinic set up and to provide rationale.Methods: This cross-sectional, observational study was conducted over a period of 2 months (May 2017- June 2017). Details of demographic data, duration and family history of diabetes, antidiabetic medications prescribed, history of comorbid diseases and drugs prescribed by physician for the treatment of comorbid diseases were collected in a structured format. Height and weight were recorded, and body mass index was calculated.Results: Study population included 294 patients and patients in the age groups of 40-59 years formed the bulk. 39% patients were overweight and 19.39% were obese. 93.20% patients were prescribed with metformin. 37 patients received insulin injection. 64.29% received more than one antidiabetic drug. Hypertension (82.05%) was the most common comorbid disease. Amlodipine was the most commonly prescribed antihypertensive drug.Conclusions: Metformin was the most commonly prescribed antidiabetic drug. Utilization of newer antidiabetic drug is inferior. Use of rationale fixed dose combination improves patient compliance.

Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c)

2007 ◽  
Vol 115 (S 1) ◽  
Author(s):  
N Ewald ◽  
C Kaufmann ◽  
A Raspe ◽  
HU Kloer ◽  
RG Bretzel ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Pancreatic Diseases ◽  
Prevalence Of Diabetes Mellitus

Trends in Type 2 Diabetes Mellitus Complications, Drug Utilization, and Laboratory Outcomes, 2012–2017

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1659-P
Author(s):  
RADHIKA NAIR ◽  
ZHENXIANG ZHAO ◽  
PRANAV GANDHI ◽  
YONG LI ◽  
KIMBERLY BRODOVICZ ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Drug Utilization

Prevalence of diabetes mellitus and impaired glucose tolerance among second-generation Japanese-American men

Diabetes ◽  
1987 ◽  
Vol 36 (6) ◽  
pp. 721-729 ◽  
Author(s):  
W. Y. Fujimoto ◽  
D. L. Leonetti ◽  
J. L. Kinyoun ◽  
L. Newell-Morris ◽  
W. P. Shuman ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Glucose Tolerance ◽  
Impaired Glucose Tolerance ◽  
Second Generation ◽  
Japanese American ◽  
Prevalence Of Diabetes Mellitus

The Role of Diabetes Mellitus in Diseases of the Gallbladder and Biliary Tract

2020 ◽  
Vol 16 (9) ◽  
pp. 931-948
Author(s):  
Benjamin Rahmani ◽  
Jason Gandhi ◽  
Gunjan Joshi ◽  
Noel L. Smith ◽  
Inefta Reid ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Risk Factors ◽  
Diabetic Neuropathy ◽  
Gallbladder Cancer ◽  
Biliary Tract ◽  
Treatment Approach ◽  
Database Search ◽  
Heavy Burden ◽  
Prevalence Of Diabetes Mellitus

Background: The increasing prevalence of diabetes mellitus worldwide continues to pose a heavy burden. Though its gastrointestinal impact is appropriately recognized, the lesser known associations may be overlooked. Objective: We aim to review the negative implications of diabetes on the gallbladder and the biliary tract. Methods: A MEDLINE® database search of literature was conducted with emphasis on the previous five years, combining keywords such as "diabetes," "gallbladder," and "biliary". Results: The association of diabetes to the formation of gallstones, gallbladder cancer, and cancer of the biliary tract are discussed along with diagnosis and treatment. Conclusion: Though we uncover the role of diabetic neuropathy in gallbladder and biliary complications, the specific individual diabetic risk factors behind these developments is unclear. Also, in addition to diabetes control and surgical gallbladder management, the treatment approach also requires further focus.

scholarly journals Cost of Management of Diabetes Mellitus: A Pan India Study

2021 ◽  
pp. 097275312199849
Author(s):  
Raghuram Nagarathna ◽  
M Madhava ◽  
Suchitra S Patil ◽  
Amit Singh ◽  
K. Perumal ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Urban Areas ◽  
Noncommunicable Disease ◽  
Cost Of Treatment ◽  
Rural And Urban Areas ◽  
Cost Of Disease ◽  
Rural And Urban ◽  
Significant Difference ◽  
The Cost ◽  
Prevalence Of Diabetes Mellitus

Background: Diabetes mellitus is a major noncommunicable disease. While mortality rates are increasing, the costs of managing the disease are also increasing. The all-India average monthly expenditure per person (pppm) is reported to be ₹ 1,098.25, which translates to an annual expenditure of ₹13,179 per person. Purpose: While a number of studies have gone into the aspect of the cost of disease management, we do not find any study which has pan-India reach. We also do not find studies that focus on differences (if any) between rural and urban areas, age or on the basis of gender. We planned to report the cost of illness (COI) in diabetes individuals as compared to others from the data of a pan-India trial. Methods: Government of India commissioned the Indian Yoga Association to study the prevalence of diabetes mellitus in India in 2017. As part of the questionnaire, the cost of treatment was also captured. Data collected from 25 states and union territories were analyzed using the analysis of covriance (ANCOVA) test on SPSS version 21. Results: There was a significant difference ( P < .05) between the average expenses per person per month (pppm) of individuals with self-reported known diabetes (₹1,357.65 pppm) and others (unknown and/or nondiabetes individuals–₹ 999.91 pppm). Similarly, there was a significant difference between rural (₹2,893 pppm) and urban (₹4,162 pppm) participants and between those below (₹1,996 pppm) and above 40 years (₹5,059 pppm) of age. Conclusion: This preliminary report has shown that the COI because of diabetes is significantly higher than others pointing to an urgent need to promote disease-preventive measures.

Sign in / Sign up

Export Citation Format

Share Document